AIDO

AIDO

Innovative platform enhancing interventional endoscopy with improved control, reduced procedure time, and increased patient safety. Learn more

Launch date
Market cap
-
Enterprise valuation
CAD600—900k (Dealroom.co estimates Oct 2022.)
Strasbourg Grand Est (HQ)

  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Seed

€100k

Seed
Total FundingCAD150k

Recent News about AIDO

Edit
More about AIDOinfo icon
Edit

AIDO Health is a pioneering company in the healthcare technology sector, focusing on revolutionizing interventional endoscopy. The company aims to enhance the precision and control of endoscopic procedures, thereby reducing both physician and patient discomfort. AIDO's platform is designed to simplify and expedite endoscopic procedures, improving user experience and patient safety. The company serves healthcare providers, particularly those specializing in gastroenterology and minimally invasive surgery. Operating in the medical technology market, AIDO's business model revolves around the development and sale of advanced endoscopic equipment and related software solutions. Revenue is generated through the direct sale of these products to hospitals and clinics, as well as through potential licensing agreements and partnerships with medical device manufacturers. Extensive usability research involving over 60 key opinion leaders and novice endoscopists has validated the efficacy and user-friendliness of AIDO's platform. This research confirms that AIDO's technology significantly decreases procedure time and enhances control during interventional procedures, ultimately increasing patient safety.

Keywords: interventional endoscopy, healthcare technology, patient safety, precision control, medical devices, usability research, gastroenterology, minimally invasive surgery, endoscopic equipment, healthcare providers.